Skip to content
healthcare.dev

Irbesartan

NDC 65162-285, Irbesartan, tablet, from Amneal Pharmaceuticals LLC.

Product NDC
65162-285
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204740
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-285 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN150 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
65162-285-036516202850330 TABLET in 1 BOTTLE (65162-285-03)
65162-285-096516202850990 TABLET in 1 BOTTLE (65162-285-09)
65162-285-11651620285111000 TABLET in 1 BOTTLE (65162-285-11)
65162-285-5065162028550500 TABLET in 1 BOTTLE (65162-285-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8c9bb449-6341-4f24-9d38-6ca952e07122

Use it

Look up 65162-285 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-285 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-285. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.